Most recently, ATP8B1 was identified as a prognostic biomarker for prostate cancer and lung squamous cell carcinoma, and that a higher ATP8B1 expression was associated with a better patient prognosis [233,234]. This evidence concerns the gene ATP8B1 and Familial prostate cancer.